Item 2.02. Results of Operations and Financial Condition
On April 6, 2020, Natus Medical Incorporated (the "Company") issued a press
release announcing preliminary first quarter revenue and withdrawing full year
2020 guidance.
The information in this Item 2.02 and the exhibit attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934
(the "Exchange Act") or otherwise subject to the liabilities of that Section,
nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as shall be expressly set
forth by specific reference in such a filing.
Item 7.01. Regulation FD Disclosure.
The April 6, 2020 press release furnished as Exhibit 99.1 hereto also provides
an update on the Company's current business operations as a result of the
uncertainty created by COVID-19 pandemic and withdraws guidance for the full
year 2020 in light of the COVID-19 pandemic.
The information under this Item 7.01 and in Exhibit 99.1, is being furnished and
is not being filed for purposes of Section 18 of the Securities Exchange Act of
1934 and is not to be incorporated by reference into any filing of the
registrant under the Securities Act of 1933 or the Securities Exchange Act of
1934, whether made before or after the date hereof, regardless of any general
incorporation language in any such filing, except as shall be expressly set
forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Description
99.1 Press release dated April 6, 2020.
The cover page from this Current Report on Form 8-K, formatted in Inline
104 XBRL (included as Exhibit 101).
© Edgar Online, source Glimpses